Your browser doesn't support javascript.
loading
Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study.
Matulonis, Ursula A; Lorusso, Domenica; Oaknin, Ana; Pignata, Sandro; Dean, Andrew; Denys, Hannelore; Colombo, Nicoletta; Van Gorp, Toon; Konner, Jason A; Marin, Margarita Romeo; Harter, Philipp; Murphy, Conleth G; Wang, Jiuzhou; Noble, Elizabeth; Esteves, Brooke; Method, Michael; Coleman, Robert L.
Affiliation
  • Matulonis UA; Dana-Farber Cancer Institute, Boston, MA.
  • Lorusso D; Fondazione Policlinico Universitario A. Gemelli, IRCCS and Catholic University of Sacred Heart, Rome, Italy.
  • Oaknin A; Gynaecologic Cancer Programme, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Pignata S; Istituto Nazionale Tumori di Napoli Fondazione G Pascale IRCCS, Naples, Italy.
  • Dean A; WA Medical Oncology St John of God Subiaco Hospital, Subiaco, WA, Australia.
  • Denys H; Ghent University Hospital, Ghent, Belgium.
  • Colombo N; European Institute of Oncology IRCCS, Milan, Italy.
  • Van Gorp T; University of Milan-Bicocca, Milan, Italy.
  • Konner JA; University Hospital of Leuven, Leuven Cancer Institute, Leuven, Belgium.
  • Marin MR; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Harter P; Institut Català d'Oncologia/Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
  • Murphy CG; Ev. Kliniken Essen-Mitte, Essen, Germany.
  • Wang J; Bon Secours Hospital and Clinical Trials, Cork, Ireland.
  • Noble E; ImmunoGen Inc, Waltham, MA.
  • Esteves B; ImmunoGen Inc, Waltham, MA.
  • Method M; ImmunoGen Inc, Waltham, MA.
  • Coleman RL; ImmunoGen Inc, Waltham, MA.
J Clin Oncol ; 41(13): 2436-2445, 2023 05 01.
Article in En | MEDLINE | ID: mdl-36716407
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Immunoconjugates / Antineoplastic Agents Limits: Female / Humans Language: En Journal: J Clin Oncol Year: 2023 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Immunoconjugates / Antineoplastic Agents Limits: Female / Humans Language: En Journal: J Clin Oncol Year: 2023 Document type: Article Affiliation country: